Key facts
- This page summarizes Charles B. Lee's Form 3 filing for MEI Pharma, Inc. (MEIP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 30 Jul 2025, 16:18.
Charles B. Lee - 22 Jul 2025 Form 3 Insider Report for MEI Pharma, Inc. (MEIP)
- Reporting relationship
- Director
- Issuer ticker
- MEIP
- Reported as of
- 22 Jul 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 30 Jul 2025, 16:18:48 UTC
- Prior SEC filing
- 02 Jul 2025
- Next SEC filing
- 02 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Justin J. File, as Attorney-in-fact for the Reporting Person
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles B. Lee filed Form 3 for MEI Pharma, Inc. (MEIP) on 30 Jul 2025.
Change
- Previous filing in this sequence was filed on 02 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001751744
Primary reporting owner
Lee Charles Benjamin
- Relationship
- Director
- Address
- 9920 PACIFIC HEIGHTS BLVD., SUITE 150, SAN DIEGO
- Signature
- /s/ Justin J. File, as Attorney-in-fact for the Reporting Person
- Signature date
- 30 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MEIP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 292,397
- Date
- 22 Jul 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.